Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05776823 · ClinicalTrials.gov registry record · NA
Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)
A NA study of Opioid Use Disorder and Overdose, sponsored by University of Arkansas.
- Active
- Registry status
- NA
- Development phase
- 267
- Enrollment target
- 1
- Study location
NCT05776823 is a NA study of Opioid Use Disorder and Overdose that is active but no longer recruiting, run by University of Arkansas. The registered enrollment target is 267 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05776823, a NA study of Opioid Use Disorder and Overdose, is active but no longer recruiting, sponsored by University of Arkansas.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 267 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the impact of a pharmacist-led intervention to expand access to medications for opioid use disorder (MOUD) on racial/ethnic differences in opioid-related overdose among individuals diagnosed with opioid use disorder (OUD) currently incarcerated in a carceral setting. In this study, participants will be screened for opioid use, trained to administer Narcan nasal spray, receive motivational counseling and referral to treatment post-release from a carceral setting (a Re-Entry program) into the community.
Conditions Studied
Interventions
- BEHAVIORAL Pharmacist Narcan Training
- BEHAVIORAL BIRT
- BEHAVIORAL SMC
- BEHAVIORAL Substance Use Counselor Narcan Training
Study Locations (1)
Arkansas
- Pulaski County Regional Detention Center - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2023-05-05 |
| Est. Completion | 2026-03-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05776823
The ClinicalTrials.gov registry entry for NCT05776823 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 267 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (94% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which Pharmacist Narcan Training is the first listed.
NCT05776823 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT05776823 about?
NCT05776823 is a clinical study titled "Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)". The purpose of this study is to investigate the impact of a pharmacist-led intervention to expand access to medications for opioid use disorder (MOUD) on racial/ethnic differences in opioid-related overdose among individuals diagnosed with opioid use disorder (OUD) currently incarcerated in a carcer...
What is the current status of trial NCT05776823?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 267 participants. The study started on 2023-05-05. Estimated completion is 2026-03-17.
What conditions does trial NCT05776823 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Overdose.
What interventions are being tested in trial NCT05776823?
The interventions under investigation include: Pharmacist Narcan Training (BEHAVIORAL), BIRT (BEHAVIORAL), SMC (BEHAVIORAL), Substance Use Counselor Narcan Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05776823?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05776823 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.